EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Diabetes and Sarcopenia: Metabolomic Signature of Pathogenic Pathways and Targeted Therapies

Anamaria Andreea Danciu, Cornelia Bala iD, Georgeta Inceu iD, Camelia Larisa Vonica, Adriana Rusu iD, Gabriela Roman iD, Dana Mihaela Ciobanu iD

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms26157574 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Anamaria Andreea Danciu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Ph.D. School, "Iuliu Haṭieganu" University of Medicine and Pharmacy, 400006 Cluj-Napoca, Romania. Hauptthemen laut MEDLINE: Sarcopenia, Metabolomics, Diabetes Mellitus, Metabolome. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 80 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Diabetes mellites (DM) is a chronic disease with increasing prevalence worldwide and multiple health implications. Among them, sarcopenia is a metabolic disorder characterized by loss of muscle mass and function. The two age-related diseases, DM and sarcopenia, share underlying pathophysiological pathways. This narrative literature review aims to provide an overview of the existing evidence on metabolomic studies evaluating DM associated with sarcopenia. Advancements in targeted and untargeted metabolomics techniques could provide better insight into the pathogenesis of sarcopenia in DM and describe their entangled and fluctuating interrelationship. Recent evidence showed that sarcopenia in DM induced significant changes in protein, lipid, carbohydrate, and in energy metabolisms in humans, animal models of DM, and cell cultures. Newer metabolites were reported, known metabolites were also found significantly modified, while few amino acids and lipids displayed a dual behavior. In addition, several therapeutic approaches proved to be promising interventions for slowing the progression of sarcopenia in DM, including physical activity, newer antihyperglycemic classes, D-pinitol, and genetic USP21 ablation, although none of them were yet validated for clinical use. Conversely, ceramides had a negative impact. Further research is needed to confirm the utility of these findings and to provide potential metabolomic biomarkers that might be relevant for the pathogenesis and treatment of sarcopenia in DM.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SarcopeniaMetabolomicsDiabetes MellitusMetabolomeHumansAnimalsBiomarkersMuscle, Skeletal

Stichwörter der Autor:innen

diabetes mellitusmetabolomicsnarrative reviewsarcopeniatherapeutic approach

Substanzen

Biomarkers

Autor:innen und Institutionen

  • Ph.D. School, "Iuliu Haṭieganu" University of Medicine and Pharmacy, 400006 Cluj-Napoca, Romania.
  • Diabetes Center, Emergency Clinical County Hospital Cluj, 400006 Cluj-Napoca, Romania.
  • Department of Diabetes and Nutrition Diseases, "Iuliu Haṭieganu" University of Medicine and Pharmacy, 400006 Cluj-Napoca, Romania.

ORCID-Profile: Cornelia Bala, Georgeta Inceu, Adriana Rusu, Gabriela Roman, Dana Mihaela Ciobanu

Zitieren

APA

Danciu, A. A., Bala, C., Inceu, G., Vonica, C. L., Rusu, A., Roman, G., & Ciobanu, D. M. (2025). Diabetes and Sarcopenia: Metabolomic Signature of Pathogenic Pathways and Targeted Therapies. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26157574

Vancouver

Danciu AA, Bala C, Inceu G, Vonica CL, Rusu A, Roman G, et al. Diabetes and Sarcopenia: Metabolomic Signature of Pathogenic Pathways and Targeted Therapies. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26157574

BibTeX
@article{Danciu2025,
  author = {Danciu, Anamaria Andreea and Bala, Cornelia and Inceu, Georgeta and Vonica, Camelia Larisa and Rusu, Adriana and Roman, Gabriela and Ciobanu, Dana Mihaela},
  title = {Diabetes and Sarcopenia: Metabolomic Signature of Pathogenic Pathways and Targeted Therapies},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms26157574}
}
Kostenlos starten →